News
NWBO
0.289
+3.96%
0.011
Weekly Report: what happened at NWBO last week (1202-1206)?
Weekly Report · 6h ago
Weekly Report: what happened at NWBO last week (1125-1129)?
Weekly Report · 12/02 12:24
Weekly Report: what happened at NWBO last week (1118-1122)?
Weekly Report · 11/25 12:12
Weekly Report: what happened at NWBO last week (1111-1115)?
Weekly Report · 11/18 12:08
Northwest Biotherapeutics, Inc. Reports Financial Results for the Quarter Ended September 30, 2024
Press release · 11/16 05:40
Weekly Report: what happened at NWBO last week (1104-1108)?
Weekly Report · 11/11 12:28
Weekly Report: what happened at NWBO last week (1028-1101)?
Weekly Report · 11/04 12:23
Weekly Report: what happened at NWBO last week (1021-1025)?
Weekly Report · 10/28 12:12
Weekly Report: what happened at NWBO last week (1014-1018)?
Weekly Report · 10/21 12:06
Weekly Report: what happened at NWBO last week (1007-1011)?
Weekly Report · 10/14 12:47
Weekly Report: what happened at NWBO last week (0930-1004)?
Weekly Report · 10/07 12:32
Weekly Report: what happened at NWBO last week (0923-0927)?
Weekly Report · 09/30 12:22
Weekly Report: what happened at NWBO last week (0916-0920)?
Weekly Report · 09/23 12:20
Weekly Report: what happened at NWBO last week (0909-0913)?
Weekly Report · 09/16 12:06
Weekly Report: what happened at NWBO last week (0902-0906)?
Weekly Report · 09/09 12:22
Weekly Report: what happened at NWBO last week (0826-0830)?
Weekly Report · 09/02 12:26
Weekly Report: what happened at NWBO last week (0819-0823)?
Weekly Report · 08/26 12:23
Weekly Report: what happened at NWBO last week (0812-0816)?
Weekly Report · 08/19 12:03
Weekly Report: what happened at NWBO last week (0805-0809)?
Weekly Report · 08/12 12:07
NORTHWEST BIOTHERAPEUTICS, INC. FORM 10-Q
Press release · 08/09 21:47
More
Webull provides a variety of real-time NWBO stock news. You can receive the latest news about Northwest Bio through multiple platforms. This information may help you make smarter investment decisions.
About NWBO
Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. It has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct, is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and included treatment of a diverse range of more than a dozen types of cancers. The Company’s wholly owned subsidiaries include Flaskworks, LLC, Northwest Biotherapeutics Limited, Aracaris Capital, Ltd, Northwest Biotherapeutics B.V., and NW Bio GmbH.